Lee Ann Beausang

**Title: Lee Ann Beausang: Innovator in Cell Viability Assessment**

Introduction

Lee Ann Beausang, based in Norfolk, MA, is a notable inventor recognized for her contributions to medical diagnostics. With a focus on innovative solutions for assessing cell viability, her work is pivotal for advancing research in disease monitoring and treatment evaluation.

Latest Patents

Lee Ann holds a patent for a groundbreaking invention titled "Nuclear Matrix Protein Fluid Assay." This patent discloses methods for determining the degree of cell death in a tissue by detecting and quantifying soluble interior nuclear matrix proteins and protein fragments in body fluids and extracellular media. The methods introduced are vital for monitoring cell and tissue viability, evaluating disease progress or treatment effects, and assessing the cytotoxicity of unknown compounds. Additionally, her patent includes methods for inducing the release of these proteins and fragments from cells in soluble form.

Career Highlights

Lee Ann Beausang’s career is marked by her dedication to advancing biomedical research. She has successfully developed innovative methodologies that have significant implications for medical diagnostics and therapeutics. Her expertise in cellular biology and diagnostics has established her as a respected figure in her field.

Collaborations

Throughout her career, Lee Ann has collaborated with esteemed colleagues, including Graham P. Lidgard and Thomas E. Miller. These partnerships have enriched her research and led to the successful development of her patent, contributing to the academic and practical application of her work in the field of cell biology.

Conclusion

Lee Ann Beausang is a distinguished inventor whose work plays a crucial role in the area of cell viability assessment. With her patented methods for measuring cell death and viability, she continues to impact the medical fields significantly, paving the way for future innovations in diagnostics and therapeutic monitoring.